Evidence map›Paper›PMID 31118388›Full record

Observational studyInternal medicine (Tokyo, Japan)2019

Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.

Hideharu Hagiya, Ryohei Kokado, Akiko Ueda, Hideo Okuno, Daiichi Morii, Shigeto Hamaguchi, Norihisa Yamamoto, Hisao Yoshida, Kazunori Tomono

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. A machine learning model to predict optimal antibiotic use in hospital medicine patients.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  7. Culture-negative periprosthetic joint infections: Do we have an issue?Journal of clinical orthopaedics and trauma · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hideharu HagiyaDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Ryohei KokadoDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Akiko UedaLaboratory for Clinical Investigation, Osaka University Hospital, Japan.
Hideo OkunoDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Daiichi MoriiDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Shigeto HamaguchiDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Norihisa YamamotoDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Hisao YoshidaDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Kazunori TomonoDivision of Infection Control and Prevention, Osaka University Hospital, Japan.
Osaka University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The importance of antimicrobial stewardship is increasingly highlighted in this age of antimicrobial resistance. A better comprehension of adverse drug events (ADEs) can promote the appropriate use of antibiotics. We aimed to quantify the incidence of ADEs associated with broad-spectrum systemic antibiotics in a hospital setting. Methods We conducted a six-month prospective, observational study at Osaka University Hospital to describe the incidence of ADEs in patients hospitalized in general wards undergoing treatment with broad-spectrum antibiotics [carbapenems, piperacillin/tazobactam (PIPC/TAZ), and anti-methicillin-resistant Staphylococcus aureus agents]. The occurrence of ADE was defined as any cardiac, gastrointestinal, hepatobiliary, renal, neurologic, hematologic, dermatologic, or musculoskeletal manifestation after 48 hours or more of systemic antibiotic therapy. Results The 3 most frequently prescribed antibiotics were PIPC/TAZ (242 cases), meropenem (181 cases), and vancomycin (92 cases). Of 689 patients, 118 (17.1%) experienced ADEs, including gastrointestinal (6.4%), hepatobiliary (4.2%), dermatologic (2.5%), and renal (2.3%) manifestations. Patients treated with PIPC/TAZ, meropenem, doripenem, vancomycin, daptomycin, and teicoplanin developed ADEs at rates of 20.7%, 16.0%, 15.4%, 19.6%, 11.8%, and 10.9%, respectively. Conclusion Our study provides a quantitative value for the incidence of ADEs associated with broad-spectrum antibiotics in clinical practice. To optimize patient safety, clinicians need to be aware of the risks associated with antibiotic administration.

Indexed as

AdultAnti-Bacterial AgentsCarbapenemsDrug-Related Side Effects and Adverse ReactionsFemaleHumansIncidenceMaleMeropenemMiddle AgedPiperacillin, Tazobactam Drug CombinationProspective StudiesVancomycinYoung AdultAnti-Bacterial AgentsCarbapenemsMeropenemPiperacillin, Tazobactam Drug CombinationVancomycinadverse drug eventantibiotic stewardshipantimicrobial resistancechoosing wisely

Identifiers

PMID31118388
PMCPMC6794169
OpenAlexW2945236180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.